PAHC currently has a forward P/E ratio of 13.32, while BSX has a forward P/E of 35.50. We also note that PAHC has a PEG ratio of 0.51. This metric is used similarly to the famous P/E ratio, but ...

The COVID-19 pandemic in 2020 had a more severe impact, causing BSX stock to drop 43.5% in contrast to a 33.9% fall for the S&P 500; however, it regained its value by August 2021.

Here are some recent targets: Richard Newitter from Truist Financial set a target price of $117.0 on 04/24/2025 Marie Thibault from BTIG set a target price of $124.0 on 04/23/2025 Matt O'Brien ...

BSX Fundamentals Over Recent Years Boston Scientific’s revenues rose from $18.4 billion in 2019 to $20.2 billion in 2022, driven by an uptick in total procedures after a decline during the ...

We recently published a list of 10 Hottest Mega-Cap Stocks So Far in 2025. In this article, we are going to take a look at where Boston Scientific (NYSE:BSX) stands against other hottest mega-cap ...

Investors in Boston Scientific Corp. (Symbol: BSX) saw new options become available today, for the May 9th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

PAHC currently has a forward P/E ratio of 11.28, while BSX has a forward P/E of 35.32. We also note that PAHC has a PEG ratio of 0.43. This popular figure is similar to the widely-used P/E ratio ...